Skip to main content
Top
Published in: Clinical and Translational Oncology 6/2005

01-07-2005 | Original Articles

Localisation of COX-2 protein is different in breast ductal carcinoma and adjacent non-tumour ductal epithelium

Authors: P. Cejas, M. A. García-Cabezas, E. Casado, J. Barriuso, J. A. Fresno, E. Díaz, C. Belda-Iniesta, J. Castro, E. Espinosa, P. Zamora, J. Feliu, A. Redondo, D. A. Hardisson, M. González-Barón

Published in: Clinical and Translational Oncology | Issue 6/2005

Login to get access
Metadata
Title
Localisation of COX-2 protein is different in breast ductal carcinoma and adjacent non-tumour ductal epithelium
Authors
P. Cejas
M. A. García-Cabezas
E. Casado
J. Barriuso
J. A. Fresno
E. Díaz
C. Belda-Iniesta
J. Castro
E. Espinosa
P. Zamora
J. Feliu
A. Redondo
D. A. Hardisson
M. González-Barón
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 6/2005
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02710169

Other articles of this Issue 6/2005

Clinical and Translational Oncology 6/2005 Go to the issue

News

News

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine